Swedish Orphan Biovitrum sales and marketing update

France, Italy, Spain and the U.K. approved national reimbursement for hemophilia A drug Elocta efmoroctocog alfa from Swedish Orphan. Swedish Orphan has rights from Biogen Inc. (NASDAQ:BIIB, Cambridge, Mass.) to the long-acting recombinant fusion protein consisting of the Fc domain of human IgG1 attached to Factor VIII. ...